How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Mammography Mammography Machine Market
- By Technology Type: Full-Field Digital Mammography (FFDM), Digital Breast Tomosynthesis (DBT), Computed Radiography Mammography (CR), Screen-Film Mammography (SFM)
- By Product Type: Standalone Mammography Systems, Mammography Systems with Biopsy Capability, Mobile Mammography Units, Mammography Accessories and Consumables
- By Application: Breast Cancer Screening, Diagnostic Mammography, Breast Biopsy Guidance, Pre-surgical Localization
- By End User: Hospitals, Diagnostic Imaging Centers, Breast Cancer Clinics, Mobile Screening Units
- By Detector Type: Flat Panel Detectors, Charge-Coupled Device (CCD) Detectors, Amorphous Selenium Detectors
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Full-Field Digital Mammography (FFDM) leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Mammography Mammography Machine Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Technology Type 4
Product Type 4
Application 4
End User 4
Detector Type 3
Companies profiled
Hologic Inc.
GE Healthcare
Siemens Healthineers
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Philips Healthcare
Carestream Health
Planmed Oy
Konica Minolta Inc.
Hitachi Ltd.
Shimadzu Corporation
Dilon Technologies Inc.
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hologic Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Canon Medical Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fujifilm Holdings Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Philips Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Carestream Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Planmed Oy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Konica Minolta Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hitachi Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Shimadzu Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Dilon Technologies Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →DMS Imaging
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,021M by 2033 · 9.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Full-Field Digital Mammography (FFDM)49.5
- Digital Breast Tomosynthesis (DBT)16.5
- Computed Radiography Mammography (CR)10.6
- Screen-Film Mammography (SFM)23.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$317.6M → $728.6M · 10.9%
Europe$221.4M → $480.6M · 10.2%
Asia Pacific$202.1M → $475.6M · 11.3%
Latin America$125.1M → $243.4M · 8.7%
Middle East and Africa$96.3M → $183.5M · 8.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.682026
9.682027
9.692028
9.712029
9.722030
9.742031
9.752032
9.762033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hologic Inc.23.9
- GE Healthcare10.1
- Siemens Healthineers13.4
- Canon Medical Systems Corporation9.7
- Fujifilm Holdings Corporation6.2
- Philips Healthcare8.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology Type17.7%
Product Type16.4%
Application27.3%
End User14.9%
Detector Type23.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe22.8
- Asia Pacific22.5
- Latin America11.5
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | 81 | 92 | 75 | 86 | 80 | 93 | 85 |
| GE Healthcare | 78 | 85 | 79 | 82 | 85 | 87 | 83 |
| Siemens Healthineers | 65 | 72 | 83 | 86 | 79 | 77 | 77 |
| Canon Medical Systems Corporation | 68 | 59 | 70 | 73 | 60 | 57 | 65 |
| Fujifilm Holdings Corporation | 66 | 63 | 66 | 76 | 54 | 69 | 66 |
| Philips Healthcare | 52 | 63 | 57 | 63 | 70 | 56 | 60 |
| Carestream Health | 56 | 59 | 61 | 57 | 64 | 42 | 57 |
| Planmed Oy | 44 | 43 | 57 | 50 | 40 | 44 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hologic Inc.
- GE Healthcare
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hologic Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| GE Healthcare | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Siemens Healthineers | − | ◐ | ✓ | ✓ | ◐ | ◐ |
| Canon Medical Systems Corporation | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| Fujifilm Holdings Corporation | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Philips Healthcare | − | − | ◐ | − | ◐ | − |
| Carestream Health | ◐ | − | − | ◐ | ◐ | − |
| Planmed Oy | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Hologic Inc.85
2GE Healthcare83
3Siemens Healthineers77
4Fujifilm Holdings Corporation66
5Canon Medical Systems Corporation65
6Philips Healthcare60
7Carestream Health57
8Planmed Oy46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Hologic Inc.GE Healthcare
Challenger1
Strong scale, closing on the leaders.
Siemens Healthineers
Contender4
Focused players with pockets of strength.
Canon Medical Systems CorporationFujifilm Holdings CorporationPhilips HealthcareCarestream Health
Niche1
Specialists in a single segment or region.
Planmed Oy
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology Type in North America, then scale across Mammography Mammography Machine Market — a $255M beachhead inside a $4.70B market.
Beachhead (SOM)$255Mobtainable near-term
Serviceable (SAM)$1.62Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Full-Field Digital Mammography (FFDM)
Best fit — highest urgency & budget in Technology Type.
Economic buyer76 fit
Digital Breast Tomosynthesis (DBT)
Strong fit — clear ROI and a fast path to value.
End user67 fit
Computed Radiography Mammography (CR)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel25%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Mammography Mammography Machine Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won5%
$9.0KCAC
$48KLTV
5.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Mammography Mammography Machine Market is a resilient opportunity — $2.34B by 2033, compounding at 4.2%.
TAM · 2025$1.69Btoday
TAM · 2033$2.34Bforecast
CAGR4.2%2027–2033
Cumulative$18.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.34BTotal addressable market
SAM$841MServiceable available market
SOM$171MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.2% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.34BLarge & growingTAM by 2033 at 4.2% CAGR
$841MServiceable nowreachable with today’s model
$171MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.83BBear2.7% CAGR
$2.34BBase4.2% CAGR
$3.00BBull5.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Mammography Mammography Machine Market — a $5.60B market by 2033. Plan: grow share from 8.6% to 14.5%.
Market size · 2033$5.60Btotal addressable
Market CAGR3.4%2027–2033
Target share14.5%from 8.6% today
Revenue ambition$812Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.6% | 14.5% | On track |
| Revenue | $446M | $812M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 29.3% | 41.1% | On track |
| Customer retention | 85.1% | 96.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Type capability
A defensible second engine — invest in Product Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $87M capacity & capability investment
- Greenlight bolt-on M&A in Product Type
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Mammography Mammography Machine Market conversation — a $3.40B market you can size, segment and defend in minutes.
Market size · 2033$3.40Btotal opportunity
Growth5.2%CAGR to 2033
Addressable buyers977+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 4 mopayback period
$71K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Hologic Inc.GE HealthcareSiemens HealthineersCanon Medical Systems CorporationFujifilm Holdings CorporationPhilips HealthcareCarestream HealthPlanmed Oy+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Mammography Mammography Machine Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Mammography Mammography Machine Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Mammography Imaging Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportMammography Flat Panel Detectors Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMammography Displays Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportMammography Biopsy Chair Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportMammographic X Ray Equipment Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMammographic Radiographic Unit Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportMammalian Transient Protein Expression Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMammalian Single Cell Analysis Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportMammalian Protein Expression Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMammalian Polyclonal IgG Antibody Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportMammalian Expression Vectors Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportMammalian Derived Proteins Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.